Skip to content

Apotheek Wilderen

Active
Private limited companyfounded 1984active for 41 yearsZoutleeuwsesteenweg 128, 3803 Sint-Truiden, BelgiumKBO/BCE: BE 0426.952.923
Summary

Apotheek Wilderen has been active since 1984 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €281,775 and a net result of €179,708. Equity has been growing by about 23% per year since 2018. Its solvency ranks better than 67% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 17-12-1984 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.026.050.183 3803 Sint-Truiden, since 01-01-1985
Financial year end
31 December
Peppol
Reachable since 30-10-2025

Board and ownership

Board
Shareholders
  • Juclé· score 9430-06-2025 annual accounts of Juclé

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€190,214
▲ 21.8%
Turnover
≈ €890,000
estimated
Profit
€179,708
▲ 25.1%
Equity
€281,775
▲ 11.8%
Total assets
€526,344
▼ 24.6%
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.15, cash €147,736Founded in 1984Equity €281,775 (53.5% of total assets)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 74% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 79+18
equity 53.5% of total assets
Liquidity 62+7
short-term debt 46.5% · cash 28.1%
Profitability 100+11
return on assets 34.1%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: 0.1%▼ -0.1 percentage points vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025lowest value 11-2025: 0.1%● unchanged vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025lowest value 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.15 (1.57 in 2024), above the usual 1.5. Short-term debt is 46.5% and cash 28.1% of total assets. 46.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 67% of them on solvency, 69% on liquidity, 96% on profitability and 63% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.15, cash €147,736
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1984
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €281,775 (53.5% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
7 days early
2024
4 days late
2023
9 days early
2022
13 days early
2021
3 days late
2020
8 days early
2019
37 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 10 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 86% of companies in retail tradesector median €27,601 · 12,764 companies €179,708 View
  • Positive: 8 profitable years in a rowprofit 2025: €179,708 8 years View

Recent changes

  1. · Gazette deed Company renamed from APOTEEK DAMS D. to Apotheek WilderenResignation: JULIE ERAERTS (manager and director) · Permanent representative: ERAERTS Julie · Reappointment: JULIE ERAERTS (director)
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as Apotheek Wilderen: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €537,000 and €767,000, founded between 1973 and 1990.

CompanyTotal assetsGross margin
Apotheek Wilderen Sint-Truiden€526,344€190,214
PHARMACIE CONCORDE DE NAMUR Sambreville€657,808€164,533
Pharmacie BLECKER-MARTINEZ Trooz€557,202€156,798
Apotheek Noben Sint-Truiden€536,605€134,663
APOTHEEK SAGON MATTE Genk€767,259€230,287
APOTHEEK MEES HAACHT CENTRUM Haacht€767,466€196,602
Apotheek Vandewalle Dendermonde€630,332€131,828
Full comparison

Key facts about Apotheek Wilderen

What is the company number of Apotheek Wilderen?
The company number of Apotheek Wilderen is 0426.952.923. The VAT number is the same number with BE in front: BE 0426.952.923.
Where is Apotheek Wilderen based?
The registered office is at Zoutleeuwsesteenweg 128, 3803 Sint-Truiden.Company details
What does Apotheek Wilderen do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Wilderen?
The legal form of Apotheek Wilderen is Private limited company (BV).
When was Apotheek Wilderen founded?
Apotheek Wilderen was founded on 17-12-1984.
Is Apotheek Wilderen still active?
Yes, Apotheek Wilderen is an active enterprise in the KBO register.
What is the turnover of Apotheek Wilderen?
The turnover in financial year 2025 is ≈ €890,000. This figure is estimated from the gross margin of €190,214 and 51 comparable companies (NACE 477). It probably lies between €600,000 and €1.7m.Financials
Is Apotheek Wilderen profitable?
In financial year 2025, Apotheek Wilderen made a profit of €179,708.
Where can I find the annual accounts of Apotheek Wilderen?
Apotheek Wilderen filed 41 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Wilderen due?
Apotheek Wilderen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.